PubMed · 1997 · 40 citations · 13 references
MedicineOphthalmologyPathologyOcular DiseaseOcular PathologyOphthalmic PathologyCorneal DiseaseCorneal DisordersCorneal PathologyImmunopathology Of The EyeIris DiseaseCorneal ImmunopathologyImmunofluorescence FindingsImmunofluorescence StainingIridocorneal Endothelial SyndromeIris Atrophy
PURPOSE: To test the hypothesis that the aberrant, cytokeratin-expressing cells that replace endothelium in the iridocorneal endothelial (ICE) syndrome are of endothelial origin. METHODS: Corneas from four patients with Chandler's syndrome and three with essential iris atrophy were examined by two-color immunofluorescence for simultaneous expression of cytokeratins and two markers of endothelial lineage: vimentin and the antigen recognized by the antiendothelial monoclonal antibody 2B4.14.1. RESULTS: In six corneas, unequivocal endothelial staining for cytokeratins was present; in each of these, cells coexpressing cytokeratins and the two endothelial markers were clearly identifiable. In the remaining cornea, weak cytokeratin staining that colocalized with vimentin was present. CONCLUSIONS: These results lend strong support to the hypothesis that the "epithelial-like" endothelial cells in ICE syndrome are cells of endothelial lineage rather than heterotopia of epithelial cells; these cells probably arise via a metaplastic transformation of preexisting endothelium.
13
Epithelialization of the corneal endothelium in posterior polymorphous dystrophy.
Merlyn M. Rodrigues, Tung‐Tien Sun, Jay Krachmer et al. · PubMed · 1980 · 67 citations
Medicine, Cell Biology, Pathology +11